Global Nicotinamide Riboside (NR) Competitive Landscape Professional Research Report 2024

Global Nicotinamide Riboside (NR) Competitive Landscape Professional Research Report 2024

Research Summary

Nicotinamide riboside (NR) is a form of vitamin B3, also known as niacin or nicotinic acid. It is a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme that plays a crucial role in various cellular processes, including energy metabolism, DNA repair, and regulation of gene expression. NR can be found naturally in trace amounts in some foods like milk, yeast, and certain vegetables, but it is also available as a dietary supplement. Research suggests that NR supplementation may support cellular health and function by boosting NAD+ levels, which decline with age and in certain health conditions. Some potential benefits of NR supplementation include improved mitochondrial function, enhanced metabolism, and protection against age-related decline. However, further studies are needed to fully understand the effects and potential therapeutic applications of NR supplementation.

According to DIResearch's in-depth investigation and research, the global Nicotinamide Riboside (NR) market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Nicotinamide Riboside (NR) include ChromaDex, Genex Formulas, Shandong Tianming Pharmaceutical, Bontac, Longer Livetech, Tiantai Biotechnology, EnzymeWorks, Suzhou MyLand Pharm & Nutrition, Shenzhen Ejion Biotechnology, Zhejiang Jiahua, Weitai Pharmaceutical etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Nicotinamide Riboside (NR). Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Nicotinamide Riboside (NR) market. The report data covers historical data from 2018 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Nicotinamide Riboside (NR) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Nicotinamide Riboside (NR) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Nicotinamide Riboside (NR) Include:

ChromaDex

Genex Formulas

Shandong Tianming Pharmaceutical

Bontac

Longer Livetech

Tiantai Biotechnology

EnzymeWorks

Suzhou MyLand Pharm & Nutrition

Shenzhen Ejion Biotechnology

Zhejiang Jiahua

Weitai Pharmaceutical

Nicotinamide Riboside (NR) Product Segment Include:

Purity ≤98%

Purity ＞98%

Nicotinamide Riboside (NR) Product Application Include:

Health Supplement

Pharmaceutical Additives

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Nicotinamide Riboside (NR) Capacity and Production Analysis

Chapter 3: Global Nicotinamide Riboside (NR) Industry PESTEL Analysis

Chapter 4: Global Nicotinamide Riboside (NR) Industry Porter’s Five Forces Analysis

Chapter 5: Global Nicotinamide Riboside (NR) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 6: Global Nicotinamide Riboside (NR) Market Size and Forecast by Type and Application Analysis

Chapter 7: North America Nicotinamide Riboside (NR) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: Europe Nicotinamide Riboside (NR) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: China Nicotinamide Riboside (NR) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: APAC (Excl. China) Nicotinamide Riboside (NR) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Latin America Nicotinamide Riboside (NR) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Middle East and Africa Nicotinamide Riboside (NR) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 13: Global Nicotinamide Riboside (NR) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 14: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 15: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 16: Research Findings and Conclusion

Chapter 17: Methodology and Data Sources